As phase three clinical trials for about 10 vaccines are currently underway, DBS Group Research believes that airline food caterer SATS will recover faster than expected.

The brokerage has upgraded the stock to a “buy” call from “hold” and raised its target price to $3.66 from $3.15 previously.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook